I am involved as the statistician in a small trial of the use of a topical medication in a surgical intervention. The intervention occurs in the leg. We in the clinical research group assumed control of this trial after the PI (surgeon) started the trial. The endpoint is reoccurrence within the leg of the original condition.
We discovered after the fact that the PI has begun to enroll both legs in some cases, treating each separately. The PI wishes to treat each leg independently. I do not. In addition, at the end of the trial, an unknown proportion of cases will have two legs treated – to date, it is 1 of 17 cases or thereabouts. Of the 50 cases who are to be treated, we could possibly expect 3-5 to have 2 legs treated.
I have contended that any publication of this trial will require evidence that the assumption of independence of the two limbs for a given person is a reasonable one. The PI wishes to assume independence simply on his say-so.
For those of you who have and are currently serving as referees, what say you? Must a strong case for independence be made? Or would you allow a trial with a simple assumption of independence to be considered?
Paul A. Thompson
| ----------------------------------------------------------------------- Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain privileged and confidential information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message. |
--
To post a new thread to MedStats, send email to MedS...@googlegroups.com .
MedStats' home page is http://groups.google.com/group/MedStats .
Rules: http://groups.google.com/group/MedStats/web/medstats-rules
On Jul 10, 2012, at 1:53 PM, Thompson,Paul wrote:
> I am involved as the statistician in a small trial of the use of a topical medication in a surgical intervention. The intervention occurs in the leg. We in the clinical research group assumed control of this trial after the PI (surgeon) started the trial. The endpoint is reoccurrence within the leg of the original condition.
>
> We discovered after the fact that the PI has begun to enroll both legs in some cases, treating each separately. The PI wishes to treat each leg independently. I do not. In addition, at the end of the trial, an unknown proportion of cases will have two legs treated – to date, it is 1 of 17 cases or thereabouts. Of the 50 cases who are to be treated, we could possibly expect 3-5 to have 2 legs treated.
>
> I have contended that any publication of this trial will require evidence that the assumption of independence of the two limbs for a given person is a reasonable one. The PI wishes to assume independence simply on his say-so.
>
> For those of you who have and are currently serving as referees, what say you? Must a strong case for independence be made? Or would you allow a trial with a simple assumption of independence to be considered?
>
I serve as a statistical referee for PLoS Medicine, and not only would I NOT accept an author’s “say-so” that two legs on one person were independent, but I would be extremely skeptical of any evidence that they were. If a test said my right leg was unrelated to my left, I would throw out the test. If reading such an article, I would probably suggest using only one leg from each person.
Peter
In general, I’d agree with this suggestion, but with so few data being paired, I think it better to KISS and lose a small amount of data rather than go complex for a slightly larger N
Peter
--
To post a new thread to MedStats, send email to MedS...@googlegroups.com .
MedStats' home page is http://groups.google.com/group/MedStats .
Rules: http://groups.google.com/group/MedStats/web/medstats-rules
--
To post a new thread to MedStats, send email to MedS...@googlegroups.com .